Clinical and Biochemical Evaluation of Lozenges Containing Lactobacillus reuteri as an Adjunct to Non‐Surgical Periodontal Therapy in Chronic Periodontitis
2015/03/05 by Gizem İnce, Gizem İnce Kuka, Hare Gürsoy +5 · 27 citations
Dentistry · Agricultural and Biological Sciences · Biochemistry, Genetics and Molecular Biology · #Oral microbiology and periodontitis research #Probiotics and Fermented Foods #Gut microbiota and health
paper · doi:10.1902/jop.2015.140612
Abstract
BACKGROUND: This study evaluates the effects on clinical and biochemical parameters of Lactobacillus reuteri-containing probiotic supplementation adjunctive to initial periodontal therapy in patients with chronic periodontitis (CP). METHODS: Thirty patients with CP were included and divided into two groups. Every patient had, in each quadrant, ≥2 teeth each with approximal sites with a probing depth (PD) of 5 to 7 mm and gingival index (GI) of ≥2. The test group received scaling and root planing (SRP) and probiotic-containing lozenges. The control group received SRP and placebo lozenges. Plaque index (PI), GI, bleeding on probing (BOP), PD, and attachment gain were measured. Gingival crevicular fluid (GCF) was sampled for the analysis of matrix metalloproteinase (MMP)-8 and tissue inhibitor of metalloproteinase (TIMP)-1 by enzyme-linked immunosorbent assay. All evaluations were performed at baseline and on days 21, 90, 180, and 360. RESULTS: Differences in intergroup comparisons of PI, GI, BOP, and PD were found to be significant (P <0.05) in favor of the test group at all time points. Decreased GCF MMP-8 levels and increased TIMP-1 levels were found to be significant up to day 180 (P <0.05). Mean values of attachment gain were significantly higher in the test group compared with the control group on days 90, 180, and 360. CONCLUSIONS: Lozenges containing L. reuteri may be a useful supplement in moderately deep pockets of patients with CP. Low MMP-8 and high TIMP-1 levels may indicate the role of the lozenges in reduction of inflammation-associated markers up to day 180.
Cited by
- The efficacy of lactic acid bacteria-based toothpaste on oral health: a systematic review and meta-analysis
- Maintaining homeostatic control of periodontal bone tissue
- Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats. [europepmc]
- Effects of Bifidobacterium probiotic on the treatment of chronic periodontitis: A randomized clinical trial. [europepmc]
- A dual-strain Lactobacilli reuteri probiotic improves the treatment of residual pockets: A randomized controlled clinical trial. [europepmc]
- Effect of probiotics as a complement to non-surgical periodontal therapy in chronic periodontitis: a systematic review. [europepmc]
- Effectiveness of Probiotic Lozenges in Periodontal Management of Chronic Periodontitis Patients: Clinical and Immunological Study. [europepmc]
- Mitigation of the Toxic Effects of Periodontal Pathogens by Candidate Probiotics in Oral Keratinocytes, and in an Invertebrate Model. [europepmc]
- Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients. [europepmc]
- Probiotic Alternative to Chlorhexidine in Periodontal Therapy: Evaluation of Clinical and Microbiological Parameters. [europepmc]
- A concerted probiotic activity to inhibit periodontitis-associated bacteria. [europepmc]
- Maintaining homeostatic control of periodontal bone tissue. [europepmc]
- Systematic review and meta-analysis on the adjunctive use of host immune modulators in non-surgical periodontal treatment in healthy and systemically compromised patients. [europepmc]
- Pocket closure and residual pockets after non-surgical periodontal therapy: A systematic review and meta-analysis. [europepmc]
- Immunomodulation in the Treatment of Periodontitis: Progress and Perspectives. [europepmc]
- Home Oral Care of Periodontal Patients Using Antimicrobial Gel with Postbiotics, Lactoferrin, and Aloe Barbadensis Leaf Juice Powder vs. Conventional Chlorhexidine Gel: A Split-Mouth Randomized Clinical Trial. [europepmc]
- Paraprobiotics in Non-Surgical Periodontal Therapy: Clinical and Microbiological Aspects in a 6-Month Follow-Up Domiciliary Protocol for Oral Hygiene. [europepmc]
- The Clinical, Microbiological, and Immunological Effects of Probiotic Supplementation on Prevention and Treatment of Periodontal Diseases: A Systematic Review and Meta-Analysis. [europepmc]
- Probiotic Species in the Management of Periodontal Diseases: An Overview. [europepmc]
- Nisin probiotic prevents inflammatory bone loss while promoting reparative proliferation and a healthy microbiome. [europepmc]
- Probiotics in Periodontal and Peri-Implant Health Management: Biofilm Control, Dysbiosis Reversal, and Host Modulation. [europepmc]
- Antimicrobial potential of known and novel probiotics on in vitro periodontitis biofilms. [europepmc]
- Clinical, microbiological and immunological short, medium and long-term effects of different strains of probiotics as an adjunct to non-surgical periodontal therapy in patients with periodontitis. Systematic review with meta-analysis. [europepmc]
- The Role of the Oral Microbiome in the Development of Diseases. [europepmc]
- Manipulating the diseased oral microbiome: the power of probiotics and prebiotics. [europepmc]
- The Anti-Inflammatory and Curative Exponent of Probiotics: A Comprehensive and Authentic Ingredient for the Sustained Functioning of Major Human Organs. [europepmc]
- Microbial dysbiosis in periodontitis and peri-implantitis: pathogenesis, immune responses, and therapeutic. [europepmc]
Related